Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $527.12 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $253.58 | 3 | $0 (2024) |
| CONMED Corporation | $130.30 | 1 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $97.08 | 1 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $22.21 | 1 | $0 (2022) |
| Lundbeck LLC | $12.19 | 1 | $0 (2022) |
| Gilead Sciences, Inc. | $11.76 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $123.52 | 1 | Neurocrine Biosciences, Inc. ($123.52) |
| 2023 | $242.04 | 2 | CONMED Corporation ($130.30) |
| 2022 | $64.48 | 4 | Otsuka America Pharmaceutical, Inc. ($22.21) |
| 2021 | $97.08 | 1 | Avanir Pharmaceuticals, Inc. ($97.08) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $123.52 | General |
| Category: Neuropsychiatry | ||||||
| 06/20/2023 | CONMED Corporation | AIRSEAL (Device) | Food and Beverage | In-kind items and services | $130.30 | General |
| Category: GENERAL SURGERY | ||||||
| 02/23/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $111.74 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2022 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $12.19 | General |
| Category: PSYCHIATRY | ||||||
| 09/07/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Neuropsychiatry | ||||||
| 05/17/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: HCV | ||||||
| 03/26/2021 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $97.08 | General |
| Category: pseudobulbar affect (PBA) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 19 | 116 | $30,004 | $10,373 |
| 2021 | 4 | 248 | 1,273 | $453,976 | $191,385 |
| 2020 | 3 | 47 | 169 | $49,169 | $16,879 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 116 | $30,004 | $10,373 | 34.6% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 87 | 378 | $244,188 | $93,336 | 38.2% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 125 | 712 | $170,168 | $81,474 | 47.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 143 | $33,680 | $13,965 | 41.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 40 | $5,940 | $2,610 | 43.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 132 | $33,000 | $11,253 | 34.1% |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2020 | 13 | 18 | $11,628 | $4,445 | 38.2% |
| 80307 | Testing for presence of drug | Office | 2020 | 15 | 19 | $4,541 | $1,181 | 26.0% |
About Dr. Seth Thompson, M.D
Dr. Seth Thompson, M.D is a Addiction Medicine healthcare provider based in Johnson City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2009. The National Provider Identifier (NPI) number assigned to this provider is 1467683300.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Seth Thompson, M.D has received a total of $527.12 in payments from pharmaceutical and medical device companies, with $123.52 received in 2024. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($527.12).
As a Medicare-enrolled provider, Thompson has provided services to 314 Medicare beneficiaries, totaling 1,558 services with total Medicare billing of $218,637. Data is available for 3 years (2020–2022), covering 8 distinct procedure/service records.
Practice Information
- Specialty Addiction Medicine
- Other Specialties Addiction Medicine, Psychiatry
- Location Johnson City, TN
- Active Since 07/27/2009
- Last Updated 08/21/2025
- Taxonomy Code 2084A0401X
- Entity Type Individual
- NPI Number 1467683300
Products in Payments
- INGREZZA (Drug) $253.58
- AIRSEAL (Device) $130.30
- NUEDEXTA (Drug) $97.08
- ABILIFY MAINTENA (Drug) $34.40
- Epclusa (Drug) $11.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Addiction Medicine Doctors in Johnson City
Dr. Anna Arroyo Santiago, Md, MD
Addiction Medicine — Payments: $648.98
Jerrold Schwartz, Md, MD
Addiction Medicine — Payments: $192.06
James Sheffey, Md, MD
Addiction Medicine — Payments: $178.38
Dr. Joseph Pinyard, M.d, M.D
Addiction Medicine — Payments: $80.68
Maria Zambrano, Do, DO
Addiction Medicine
Mr. Benjamin Cannon, Cprs, CPRS
Addiction Medicine